MCM
PJP icon

MAI Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

MAI Capital Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-198
Closed -$20.7K – 5117
2025
Q4 		$20.7K Hold
198
– – ﹤0.01% 2496
2025
Q3 		$18.3K Hold
198
– – ﹤0.01% 2440
2025
Q2 		$15.8K Hold
198
– – ﹤0.01% 2479
2025
Q1 		$17.1K Hold
198
– – ﹤0.01% 2252
2024
Q4 		$16.4K Buy
+198
New +$17K ﹤0.01% 2309

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $2.41B AUM 38.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAI Capital Management's PJP Position: Q1 2026 in Review

MAI Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 198 shares — an estimated $20.7K sold.

MAI Capital Management first reported a position in PJP in Q4 2024 and held it in 5 quarters. The position peaked at $20.7K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • MAI Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • MAI Capital Management sold 198 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $20.7K.
  • MAI Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2024 and held it in 5 quarters.
  • MAI Capital Management's Invesco Pharmaceuticals ETF position peaked at $20.7K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.